TORONTO, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Red White & Bloom Brands Inc. (CSE: RWB) (“RWB” or the “Company”) announces that it has completed and filed its interim financial statements for the periods ended March 31, 2025 and June 30, 2025, and the related management's discussion and analysis and CEO and CFO certificates. Copies of the noted documents are available under the Company’s profile on SEDAR+ at www.sedarplus.ca. With the filing of these documents, the Company has now brought its continuous disclos ...

The stock remains significantly down from its all-time highs.Is this the year Tilray Brands (TLRY -2.42%) finally starts its comeback? During the past five years, the company has lagged broader equities as the cannabis industry, where it is a leader, continues to fall far short of expectations. However, Tilray Brands has been on fire this year, and during the past six months alone, the stock is up more than 150% (as of Oct. 2). Yet, the shares are still well into penny stock territory and are currently trad ...

Core Insights - Cannabis stocks experienced significant movement following President Trump's endorsement of cannabidiol (CBD) for seniors, highlighting potential health benefits [1] - Major marijuana stocks saw substantial gains, with Tilray Brands increasing by 42% and Aurora Cannabis by 25%, although some of these gains were later reversed [2] Company Overview - Constellation Brands is a significant shareholder in Canopy Growth, holding approximately 26 million shares through its shell company, which could represent about 14% of Canopy's stock if converted [3] - Constellation Brands is the third-largest beer company in the U.S., also producing high-end wine and spirits, with notable brands like Corona and Kim Crawford [4] Financial Performance - Constellation Brands has a market capitalization of $24.5 billion and has seen a year-to-date decline of 37% in 2025, underperforming competitors like Boston Beer and Molson Coors [5] - The stock is currently considered overvalued with a price-to-earnings ratio of 46.4, significantly higher than its 10-year median of 25.8 [5] Dividend Information - Constellation Brands offers a dividend yield of 3%, which is above the sector average of 1.9%, with the next payment scheduled for November 13, 2025 [6]

Curaleaf Holdings, Inc. ( OTCPK:CURLF ) (TSX: CURA:CA ) reported in line financial results for Q2 2025 last August. The company announced that it will begin the expansion of international operations into Turkey. The EU recently announcedWelcome to the home of The Cannabis Report. I cover the cannabis sector and other sectors. I am most interested in technical stock analysis, option strategies, small cap strategies, and emerging markets. Feel free to contact me with any questions about publicly traded stocks ...

Group 1: Market Overview - Tech stocks are rallying following OpenAI's $500 billion valuation, contributing to a significant increase in market enthusiasm, particularly among chipmakers, which added approximately $200 billion in market value [4][2][1] - The S&P 500 is on track for its 30th all-time high this year, reflecting strong investor sentiment and market performance [3][2] - The ongoing government shutdown is causing uncertainty in economic activity, which may influence the Federal Reserve's decisions regarding interest rate cuts [120][119] Group 2: Company Insights - Tesla reported record vehicle sales, delivering 497,000 vehicles in the latest quarter, marking a 7.4% increase year-over-year, which has driven its stock to record highs [31][32] - Rivian has narrowed its annual delivery guidance due to the loss of consumer tax incentives, now expecting to deliver between 41,500 to 43,500 vehicles this year [33] - General Motors (GM) is experiencing strong sales growth, with a 10% year-over-year increase, and has announced a $1 billion impact from tariffs while investing in U.S. manufacturing [56][57] Group 3: Investment Strategies - Investment strategies are focusing on sectors like AI, robotics, and quantum technologies, with a recommendation to buy on dips and hold strong positions in leading tech names [10][12][11] - The sentiment among retail investors is cautiously optimistic, with concerns about high valuations and potential market corrections [78][81] - Gold is gaining renewed interest as a safe haven asset, with predictions of prices reaching $4,000 per ounce by mid-2026, driven by macroeconomic uncertainties and strong demand [101][106]

Core Viewpoint - Cannara Biotech Inc. intends to settle approximately $6.2 million of indebtedness through the issuance of common shares to Olymbec Investments Inc. as part of a convertible debenture agreement [1][5][6]. Debt Settlement - The company plans to settle $4.7 million in principal and approximately $1.5 million in accrued interest under the Olymbec Convertible Debenture [1][2]. - The original principal amount of the Olymbec Convertible Debenture was $5.7 million, with a prior repayment of $1 million reducing the outstanding principal to $4.7 million [2]. Share Issuance Details - Cannara proposes to issue 3,462,763 common shares at a deemed price of $1.80 per share to satisfy the outstanding indebtedness, with 851,652 shares representing the repayment of interest [3]. - The issuance is subject to the policies of the TSX Venture Exchange and requires their review and approval [4]. Related Party Transaction - The transaction is classified as a "related party transaction" due to Mr. Derek Stern's significant interest in Olymbec, and Cannara intends to rely on an exemption from minority shareholder approval requirements [5]. - Following the share issuance, Olymbec will hold approximately 25.47% of Cannara's issued and outstanding common shares [6]. Corporate Governance - The Proposed Olymbec Share Issuance has been approved by independent directors of the company [7]. Investor Relations - Cannara granted 40,000 stock options to Bristol Capital Ltd. for investor relations services, with each option exercisable at $1.80 per common share [8].

Core Insights - Tilray Brands, Inc. is a significant player in the cannabis industry, known for its diverse product offerings and strategic acquisitions, including craft beer brands from Anheuser-Busch InBev, which has helped balance its revenue streams [1] - The company is set to release its quarterly earnings on October 9, 2025, with an estimated EPS of -$0.03, reflecting a 25% improvement year-over-year, and projected revenue of approximately $205.75 million, marking a 3.39% increase from the previous year [2][6] - Despite a recent stock price decline of 4.34% to $1.66, Tilray's stock has surged 38.4% over the past month, outperforming the Medical sector and the S&P 500, driven by political news and increased trading volume [3][6] Financial Metrics - Tilray's financial metrics indicate a complex valuation scenario, with a price-to-sales ratio of approximately 1.60 and an enterprise value to sales ratio of 1.61, suggesting reasonable valuation relative to sales [4] - The company has a negative price-to-earnings ratio and earnings yield, indicating current unprofitability, alongside a negative enterprise value to operating cash flow ratio, highlighting challenges in generating cash flow [4] - Despite these challenges, Tilray maintains a strong cash position, a low debt-to-equity ratio of 0.16, and a current ratio of 2.46, reflecting financial stability and the ability to cover short-term liabilities [5]

Accessibility StatementSkip Navigation Dispositions by Mr. Lusardi under the ASDP will be reported in accordance with applicable securities laws. Each such filing will bear a notation to advise readers that the disposition is related to an ASDP. Information regarding each ASDP and transactions thereunder, as the case may be, may be accessed on SEDI at www.sedi.ca. This announcement is made pursuant to the recommended practices set forth in Staff Notice 55-317 – Automatic Securities Disposition Plans of the ...

Despite Republican efforts to block rescheduling, I believe President Trump will leverage cannabis and rescheduling to shore up support during the midterm elections, which should boost Amplify Alternative Harvest ETF (NYSEARCA:Markets rise and fall, booms come and go, and the world keeps ticking. Ultimately, I believe observing megatrends, as difficult as they can be to spot, let alone fully comprehend, can yield insights into the advance of human society, which in turn could pave the way for many useful in ...

Key Points President Trump posted a video suggesting that seniors would benefit from hemp-derived CBD. He's also suggested reclassifying marijuana on a federal level. 10 stocks we like better than Tilray Brands › Marijuana stocks are getting some attention this week following new interest from President Donald Trump. Trump on Sunday posted a video on his Truth Social account that promoted the health benefits of hemp-derived CBD for seniors, suggesting it could be included under Medicare. The video ...